takinib

N/A

Report date: 2025/03/19 11:40:47
NME

Base Information

Drug Nametakinib
Drug Alias NameTAK-1 inhibitor (Duke University Medical Center)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTGF-β activated kinase-1 inhibitors
TargetsTGF-β activated kinase-1
Therapy Area/IndicationsAutoimmune DiseasesArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDuke University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesDuke University Medical Center
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesArthritis, RheumatoidNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A